Advent Life Sciences logo

Advent Life Sciences

Europe, England, United Kingdom, London

Description

Advent Life Sciences is a venture capital firm investing in life sciences businesses.

Investor Profile

Advent Life Sciences has made 64 investments, with 5 in the past 12 months and 34% as lead.

Stage Focus

  • Series A (27%)
  • Series Unknown (23%)
  • Series B (20%)
  • Series C (11%)
  • Seed (8%)
  • Private Equity (3%)
  • Series E (3%)
  • Convertible Note (3%)
  • Series D (2%)

Country Focus

  • United States (53%)
  • United Kingdom (34%)
  • France (5%)
  • Ireland (2%)
  • Norway (2%)
  • Switzerland (2%)
  • Finland (2%)
  • Spain (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Biopharma
  • Life Science
  • Manufacturing
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Advent Life Sciences frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 7
Columbus Venture Partners
Europe, Madrid, Spain, Madrid
Co-Investments: 7
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 5
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 4
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 3
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 8

Which angels does Advent Life Sciences often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 3
BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 4
SP
Europe, Germany
Shared Deals: 1
FM
North America, United States
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
SH
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by Advent Life Sciences?

Relief Cardiovascular

Costa Mesa, California, United States

Relief Cardiovascular is an inQB8 medical technologies portfolio company.

HospitalMedicalWellness
Series AJan 8, 2025
Amount Raised: $12,000,000
Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedOct 24, 2024
Amount Raised: $31,000,000
Moximed

Hayward, California, United States

Moximed develops innovative therapies for patients with knee osteoarthritis.

BiotechnologyHealth CareMedical Device
Series DAug 13, 2024
Amount Raised: $61,000,000
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Convertible NoteAug 6, 2024
Amount Raised: $8,000,000
Beacon Therapeutics

London, England, United Kingdom

Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.

Health CareTherapeutics
Series BJun 3, 2024
Amount Raised: $170,000,000
Curve Therapeutics

Southampton, Southampton, United Kingdom

Curve develops an innovative screening platform.

Biotechnology
Series AFeb 27, 2024
Amount Raised: $51,355,077
Argá Medtech

Epalinges, Vaud, Switzerland

Argá Medtech is an Innovative Cardiac Ablation System for treating cardiac arrhythmias.

ManufacturingMedical
Series BFeb 27, 2024
Amount Raised: $58,538,679
Nalu Medical

Carlsbad, California, United States

Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.

Health CareMedicalMedical Device
Series EJan 3, 2024
Amount Raised: $85,000,000
PIC Therapeutics

Natick, Massachusetts, United States

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series AOct 19, 2022
Amount Raised: $35,000,000
Tridek-One

Évry, Ile-de-France, France

Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.

BiotechnologyHealth CareLife Science
Series UnknownSep 15, 2022
Amount Raised: $15,979,993